Cannabidiol (Receptor Life Sciences)

大麻二酚 (Receptor Life Sciences)

Report date: 2024/08/29 14:00:46

Base Information

Drug NameCannabidiol (Receptor Life Sciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB2 receptor inverse agonistsCannabinoid CB1 receptor inverse agonistsSerotonin 5-HT1 receptors modulators +[4] 
TargetsCannabinoid CB1 receptorCannabinoid CB2 receptorSerotonin 5-HT1 receptors +[4] 
Therapy Area/IndicationsAutism Spectrum Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesReceptor Life Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesReceptor Life Sciences Inc
Inactive CompaniesN/A
Active IndicationsAutism Spectrum Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A